Article: Walter Reed Army Medical Center Seeks Palatin Technologies' LeuTech for Potential Early Detection of Inhaled Anthrax Infection.

Business Editors & Health/Medical Writers

BIOWIRE2K

PRINCETON, N.J.--(BW HealthWire)--Nov. 5, 2001

Palatin Technologies, Inc. (AMEX: PTN) announced today that it has teamed with the Walter Reed Army Medical Center, Washington, D.C. to evaluate the clinical utility of Palatin's investigational infection imaging and diagnostic product, LeuTech(R), for the early detection of inhalation anthrax.

Under the agreement, made through The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., study patients exposed to anthrax will begin receiving LeuTech(R) scans this week. LeuTech(R) is a radiolabeled monoclonal antibody ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!